Delaugerre C - Search Results

1

Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies.

Gantner P, Mélard A, Damond F, Delaugerre C, Dina J, Gueudin M, Maillard A, Sauné K, Rodallec A, Tuaillon E, Plantier JC, Rouzioux C, Avettand-Fenoel V; ANRS-AC11 Quantification Working Group. Gantner P, et al. Among authors: delaugerre c. J Med Virol. 2017 Nov;89(11):2047-2050. doi: 10.1002/jmv.24874. Epub 2017 Jul 6. J Med Virol. 2017. PMID: 28617961

2

Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.

Calvez V, Costagliola D, Descamps D, Yvon A, Collin G, Cécile A, Delaugerre C, Damond F, Marcelin AG, Matheron S, Simon A, Valantin MA, Katlama C, Brun-Vézinet F. Calvez V, et al. Among authors: delaugerre c. Antivir Ther. 2002 Sep;7(3):211-8. Antivir Ther. 2002. PMID: 12487389

3

Predictive factors of virologic success in HIV-1-infected children treated with lopinavir/ritonavir.

Delaugerre C, Teglas JP, Treluyer JM, Vaz P, Jullien V, Veber F, Rouzioux C, Chaix ML, Blanche S. Delaugerre C, et al. J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1269-75. doi: 10.1097/01.qai.0000137408.78031.37. J Acquir Immune Defic Syndr. 2004. PMID: 15385734

4

Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF.

Delaugerre C, Roudiere L, Peytavin G, Rouzioux C, Viard JP, Chaix ML. Delaugerre C, et al. J Clin Virol. 2005 Mar;32(3):241-4. doi: 10.1016/j.jcv.2004.05.020. J Clin Virol. 2005. PMID: 15722030

5

Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).

Delaugerre C, Peytavin G, Dominguez S, Marcelin AG, Duvivier C, Gourlain K, Amellal B, Legrand M, Raffi F, Costagliola D, Katlama C, Calvez V. Delaugerre C, et al. J Med Virol. 2005 Nov;77(3):345-50. doi: 10.1002/jmv.20462. J Med Virol. 2005. PMID: 16173015 Clinical Trial.

6

Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.

Descamps D, Delaugerre C, Masquelier B, Ruffault A, Marcelin AG, Izopet J, Chaix ML, Calvez V, Brun-Vézinet F, Costagliola D. Descamps D, et al. Among authors: delaugerre c. J Med Virol. 2006 Feb;78(2):153-60. doi: 10.1002/jmv.20522. J Med Virol. 2006. PMID: 16372300

7

Change to a once-daily combination including boosted atazanavir in HIV-1-infected children.

Macassa E, Delaugerre C, Teglas JP, Jullien V, Tréluyer JM, Veber F, Rouzioux C, Blanche S. Macassa E, et al. Among authors: delaugerre c. Pediatr Infect Dis J. 2006 Sep;25(9):809-14. doi: 10.1097/01.inf.0000234069.37972.94. Pediatr Infect Dis J. 2006. PMID: 16940839

8

Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study.

Costagliola D, Descamps D, Assoumou L, Morand-Joubert L, Marcelin AG, Brodard V, Delaugerre C, Mackiewicz V, Ruffault A, Izopet J, Plantier JC, Tamalet C, Yerly S, Saidi S, Brun-Vezinet F, Masquelier B; Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS) AC11 Resistance Study Group. Costagliola D, et al. Among authors: delaugerre c. J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):12-8. doi: 10.1097/QAI.0b013e318074eb73. J Acquir Immune Defic Syndr. 2007. PMID: 17514016

9

Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.

Delaugerre C, Warszawski J, Chaix ML, Veber F, Macassa E, Buseyne F, Rouzioux C, Blanche S. Delaugerre C, et al. J Med Virol. 2007 Sep;79(9):1261-9. doi: 10.1002/jmv.20940. J Med Virol. 2007. PMID: 17607781

10

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.

Delfraissy JF, Flandre P, Delaugerre C, Ghosn J, Horban A, Girard PM, Norton M, Rouzioux C, Taburet AM, Cohen-Codar I, Van PN, Chauvin JP. Delfraissy JF, et al. Among authors: delaugerre c. AIDS. 2008 Jan 30;22(3):385-93. doi: 10.1097/QAD.0b013e3282f3f16d. AIDS. 2008. PMID: 18195565 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters